Benzofuro[3,2-b]pyridines as mixed ETA/ETB and selective ETB endothelin receptor antagonists

被引:34
作者
Mederski, WWKR [1 ]
Osswald, M [1 ]
Dorsch, D [1 ]
Christadler, M [1 ]
Schmitges, CJ [1 ]
Wilm, C [1 ]
机构
[1] Merck KGaA, Preclin Pharmaceut Res, D-64271 Darmstadt, Germany
关键词
antagonists; benzofuro[3,2-b]pyridines; endothelin; vasodilators;
D O I
10.1016/S0960-894X(99)00040-2
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The discovery, synthesis and structure-activity relationships of a series of novel benzofuro[3,2-b]pyridines as non-selective endothelin ETA/ETB as well as selective ETB receptor antagonists are described. The most potent non-selective inhibitor 7s displayed an IC50 of 21 nM and 41 nM for ETA and ETB receptors, respectively, whereas 7ee merely showed affinity for the ETB receptor (IC50 = 3.6 nM). (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:619 / 622
页数:4
相关论文
共 13 条
  • [1] A ''one-pot'' phase transfer alkylation/hydrolysis of o-nitrotrifluoroacetanilides. A convenient route to N-alkyl o-phenylenediamines
    Brown, SA
    Rizzo, CJ
    [J]. SYNTHETIC COMMUNICATIONS, 1996, 26 (21) : 4065 - 4080
  • [2] THE ENDOTHELIN ET(B) RECEPTOR MEDIATES BOTH VASODILATION AND VASOCONSTRICTION INVIVO
    CLOZEL, M
    GRAY, GA
    BREU, V
    LOFFLER, BM
    OSTERWALDER, R
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) : 867 - 873
  • [3] PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN REVEALED BY THE 1ST ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST
    CLOZEL, M
    BREU, V
    BURRI, K
    CASSAL, JM
    FISCHLI, W
    GRAY, GA
    HIRTH, G
    LOFFLER, BM
    MULLER, M
    NEIDHART, W
    RAMUZ, H
    [J]. NATURE, 1993, 365 (6448) : 759 - 761
  • [4] Up-regulation of endothelin-B receptors in atherosclerotic human coronary arteries
    Dagassan, PH
    Breu, V
    Clozel, M
    Kunzli, A
    Vogt, P
    Turina, M
    Kiowski, W
    Clozel, JP
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 27 (01) : 147 - 153
  • [5] Pyridazinones with a pendant acylsulfonamide moiety as endothelin receptor antagonists
    Dorsch, D
    Mederski, WWKR
    Osswald, M
    Devant, RM
    Schmitges, CJ
    Christadler, M
    Wilm, C
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (03) : 275 - 280
  • [6] Pyrrolidine-3-carboxylic acids as endothelin antagonists .2. Sulfonamide-based ETA/ETB mixed antagonists
    Jae, HS
    Winn, M
    Dixon, DB
    Marsh, KC
    Nguyen, B
    Opgenorth, TJ
    vonGeldern, TW
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (20) : 3217 - 3227
  • [7] 2. Endothelin antagonists: Evaluation of 2,1,3-benzothiadiazole as a methylendioxyphenyl bioisoster
    Mederski, WWKR
    Osswald, M
    Dorsch, D
    Anzali, S
    Christadler, M
    Schmitges, CJ
    Wilm, C
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (01) : 17 - 22
  • [8] 1,4-diaryl-2-oxo-1,2-dihyrdo-quinoline-3-carboxylic acids as endothelin receptor antagonists
    Mederski, WWKR
    Osswald, M
    Dorsch, D
    Christadler, M
    Schmitges, CJ
    Wilm, C
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (14) : 1883 - 1886
  • [9] 3.: Endothelin antagonists:: Discovery of EMD 122946, a highly potent and orally active ETA selective antagonist
    Mederski, WWKR
    Dorsch, D
    Osswald, M
    Anzali, S
    Christadler, M
    Schmitges, CJ
    Schelling, P
    Wilm, C
    Fluck, M
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (13) : 1771 - 1776
  • [10] OSSWALD M, 1996, 211 AM CHEM SOC NAT